TILInstil Bio, Inc.
Earnings
When Instil Bio, Inc. reports, what it reported each quarter, and how the stock took the results.
26 quarters. Mar 31, 2020 to Jun 30, 2026. USD.
Next results · Q3 2026Report filed
10-Q filed Nov 16, 2026
The 10-Q was filed Nov 16, 2026. Its figures are not on the desk yet.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
Latest results
- Revenue
- —
- —
- Net income
- -$4.30M
- N/M
- EPS
- -$0.63
- N/M
- Revenue
- —
- —
- Net income
- -$4.20M
- N/M
- EPS
- -$0.62
- N/M
- Revenue
- —
- —
- Net income
- -$8.19M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$13.59M
- N/M
- EPS
- -$2.01
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | Aug 13, 2026 · after-hours | Aug 13, 2026 | 44 d | 10-Q | — | — | -$0.63 | +0.4% | |
| Q1 2026 | Mar 31, 2026 | May 15, 2026 · pre-market | May 15, 2026 | 45 d | 10-Q | — | — | -$0.62 | +0.6% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | Mar 27, 2026 · pre-market | Mar 27, 2026 | 86 d | 10-K | — | — | — | 6.4% | |
| Q3 2025 | Sep 30, 2025 | Nov 13, 2025 · pre-market | Nov 13, 2025 | 44 d | 10-Q | — | — | -$2.01 | 7.2% | |
| Q2 2025 | Jun 30, 2025 | Aug 13, 2025 · pre-market | Aug 13, 2025 | 44 d | 10-Q | — | — | -$3.24 | +0.5% | |
| Q1 2025 | Mar 31, 2025 | May 13, 2025 · pre-market | May 13, 2025 | 43 d | 10-Q | — | — | -$4.32 | 7.1% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | Mar 4, 2025 · pre-market | Mar 4, 2025 | 63 d | 10-K | — | — | — | 0.8% | |
| Q3 2024 | Sep 30, 2024 | Nov 13, 2024 · pre-market | Nov 13, 2024 | 44 d | 10-Q | — | — | -$3.54 | 4.5% | |
| Q2 2024 | Jun 30, 2024 | Aug 13, 2024 · after-hours | Aug 13, 2024 | 44 d | 10-Q | — | — | -$2.29 | — | |
| Q1 2024 | Mar 31, 2024 | May 10, 2024 · pre-market | May 10, 2024 | 40 d | 10-Q | — | — | -$3.74 | — | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | Mar 21, 2024 · after-hours | Mar 21, 2024 | 81 d | 10-K | — | — | — | — | |
| Q3 2023 | Sep 30, 2023 | Nov 13, 2023 · after-hours | Nov 13, 2023 | 44 d | 10-Q | — | — | -$10.37 | — | |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 · pre-market | Aug 14, 2023 | 45 d | 10-Q | — | — | -$2.87 | — | |
| Q1 2023 | Mar 31, 2023 | May 11, 2023 · pre-market | May 11, 2023 | 41 d | 10-Q | — | — | -$8.77 | 7.5% | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 31, 2023 · pre-market | Mar 31, 2023 | 90 d | 10-K | — | — | — | 4.2% | |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 · after-hours | Nov 14, 2022 | 45 d | 10-Q | — | — | -$0.43 | — | |
| Q2 2022 | Jun 30, 2022 | Aug 12, 2022 · pre-market | Aug 12, 2022 | 43 d | 10-Q | — | — | -$0.46 | +8.4% | |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 · pre-market | May 16, 2022 | 46 d | 10-Q | — | — | -$0.42 | +12.8% | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | Mar 7, 2022 · pre-market | Mar 7, 2022 | 66 d | 10-K | $0.00 | — | — | +3.0% | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | $0.00 | −100.0% | -$0.33 | +1.3% | |
| Q2 2021 | Jun 30, 2021 | Aug 12, 2021 · after-hours | Aug 12, 2021 | 43 d | 10-Q | $0.00 | −100.0% | -$0.27 | 1.6% | |
| Q1 2021 | Mar 31, 2021 | May 13, 2021 · after-hours | May 13, 2021 | 43 d | 10-Q | $0.00 | −100.0% | -$0.66 | +10.2% | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | — | — | — | $0.00 | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | — | — | — | $52.00K | — | -$0.43 | — | |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $42.00K | — | -$0.55 | — | |
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $44.00K | — | -$0.31 | — | |
Earlier years, FY 2020 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR